// App-Quantinova.ai

801 : Non-Invasive Genetic Profiling Is Highly Applicable in Multiple Myeloma (MM) through Characterization of Circulating Tumor Cells (CTCs)

Researchers

Presenter

  • Diego Alignani

Principal Investigators

  • Lourdes Ortiz

  • Joaquin Martinez-Lopez

  • Luis Palomera

  • Maria Teresa Zudaire

  • Rafael Del Orbe

  • Jacques J.M. van Dongen

  • Alberto Orfao

  • Bruno Paiva

  • Jesus San Miguel

  • Tomas Jelinek

  • Victor Segura

  • Luzalba Sanoja

  • Maria-Jose Calasanz

  • Xabier Agirre

  • Felipe Prosper

  • Paula Rodriguez-Otero

  • Rafael Rios

Medical Centers

  • Hospital Universitario Virgen de las Nieves, Granada, Spain

  • Centro de Investigacion Medica Aplicada, University of Navarra, Clinica Universidad de Navarra, Pamplona, Spain

  • Division of Oncology, CIMA/UNAV/IDISNA, Pamplona, Spain

  • CUN, Pamplona, Spain

  • Clinica Universidad de Navarra, Pamplona, Spain

  • University of Salamanca Hospital, Salamanca, Spain

  • Centro de Investigacion del Cancer (CIC, IBMCC USAL-CSIC), Servicio General de Citometria, Universidad de Salamanca, Salamanca, Spain

  • CIMA/UNAV/IDISNA, Pamplona, Spain

  • Department. of Immunology, Laboratory for Medical Immunology, Erasmus MC Rotterdam, Rotterdam, Netherlands

  • University of Navarra, Pamplona, Spain

  • Department of Bioinformatics, CIMA/UNAV/IDISNA, Pamplona, Spain

  • Biocruces Helath Research Institute, Baracaldo, Spain

  • Complejo Hospitalario de Navarra, Pamplona, Spain

  • de Octubre, Madrid,Spain

  • Gastroenterology Unit, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain

Locations

  • Spain

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Multiple Myeloma

  • Monoclonal gammopathy

Biomarkers

  • Nerve Growth Factor

  • Circulating tumor cells

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim